Clinical applications of the 2nd generation assay for anti-TSH receptor antibodies in Graves' disease. Evaluation in patients with negative 1st generation test

Clinical Chemistry and Laboratory Medicine

Volumn 39, Issue 1, 2001, Pages 25-28

  Giovanella, L ^a   Ceriani, L ^a   Garancini, S ^a  

^a OSPEDALE DI CIRCOLO   (Italy)

Author keywords

Grave's disease; Hyperthyroidism; Thyroid autoantibodies to TSH receptor

Indexed keywords

ANTITHYROID AGENT; AUTOANTIBODY; LIOTHYRONINE; PERTECHNETIC ACID TC 99M; RADIOACTIVE IODINE; RECOMBINANT ANTIGEN; THYROTROPIN; THYROTROPIN RECEPTOR; THYROTROPIN RECEPTOR ANTIBODY; THYROXINE;

ANTIBODY DETECTION; ARTICLE; CLINICAL PRACTICE; CLINICAL STUDY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; IMMUNOASSAY; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; NODULAR GOITER; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RADIORECEPTOR ASSAY; RECURRENCE RISK; RISK ASSESSMENT; TREATMENT PLANNING;

ANTIBODIES; ANTITHYROID AGENTS; CASE-CONTROL STUDIES; CHEMISTRY, CLINICAL; GOITER; GRAVES DISEASE; HUMANS; RECEPTORS, THYROTROPIN; RECURRENCE; RISK FACTORS; SENSITIVITY AND SPECIFICITY; THYROIDITIS, AUTOIMMUNE;

EID: 0035113897     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2001.007     Document Type: Article

References (20)

1. Autoantibodies to the thyrotropin receptor
2. Autoimmune thyroid disease: Further developments in our understanding
3. Graves' ophthalmopathy: Diagnosis and management
4. The thyrotropin receptor and its role in Graves' disease
5. Thyrotropin receptor antibodies: Advances and importance of detection techniques in thyroid diseases
6. Evaluation of serum basal thyrotropin levels and thyrotropin receptor antibody activities as prognostic markers for discontinuation of antithyroid drug treatment in patients with Graves' disease
7. Optimum duration of antithyroid drug treatment determined by assay of thyroid stimulating antibody in patients with Graves' disease
8. Role of thyrotropin receptor antibodies in the development of hyperthyroidism: Follow up of nine patients with Graves' disease
9. Meta-analysis evaluation of the impact of thyrotropin receptor antibodies on long-term remission after medical therapy of Graves' disease
10. Fetal and neonatal hyperthyroidism and hypothyroidism due to maternal TSH receptor antibodies
11. Thyroid stimulating activity of TRAb not TBI as a predictor of clinical Graves' ophthalmopathy
12. Hyperthyroid Graves' disease without detectable thyrotropin receptor antibodies
13. A study of untreated Graves' patients with undetectable TSH binding inhibitor immunoglobulins and the effect of anti-thyroid drugs
14. Binding assay for thyrotropin receptor autoantibodies using the recombinant receptor protein
15. The human thyrotropin (TSH) receptor in a binding inhibition assay for TSH receptor autoantibodies
16. Second generation assay for thyrotropin receptor antibodies has superior diagnostic sensitivity for Graves' disease
17. The prognostic value of thyrotropin receptor antibody measurement in the early stages of treatment of Graves' disease with antithyroid drugs
18. Prospective multicenter study on the prediction of relapse after antithyroid drug treatment in patients with Graves' disease
19. Thyroid controversy: Stimulating antibodies
20. Association of thyrotropin receptor antibodies with the clinical features of Graves' ophthalmopathy